°Ë»ö°á°ú: ÃÑ 26°³ Áß 21 - 30 |
ºÎ±¤Æä´ÏÅäÀÎĸ½¶100mg(Æä´ÏÅäÀÎ)ÀÇ º´¿ë±Ý±â¿¡ ÇØ´çµÇ´Â Á¦Ç°
Á¦Ç°¸í¡å | ¼ººÐ¸í | ÁÖ¼ººÐÄÚµå | Ç¥ÁØÄÚµå | ÆǸŻç | °í½Ã¹øÈ£ | Àû¿ëÀÏ |
¾Ë·»½Ãĸ½¶75¹Ð¸®±×·¥(ÆȺ¸½ÃŬ¸³)_(75mg/1ĸ½¶) | palbociclib | 655201ACH | 641807240 | ±¤µ¿Á¦¾à(ÁÖ) | 20180088 | 20181102 |
¾Ë·»½Ãĸ½¶125¹Ð¸®±×·¥(ÆȺ¸½ÃŬ¸³)_(0.125g/1ĸ½¶) | palbociclib | 655202ACH | 641807260 | ±¤µ¿Á¦¾à(ÁÖ) | 20180088 | 20181102 |
¾Ë·»½Ãĸ½¶100¹Ð¸®±×·¥(ÆȺ¸½ÃŬ¸³)_(0.1g/1ĸ½¶) | palbociclib | 655203ACH | 641807250 | ±¤µ¿Á¦¾à(ÁÖ) | 20180088 | 20181102 |
¼Ò¹ßµðÁ¤(¼ÒÆ÷½ººÎºñ¸£)_(0.4g/1Á¤) | sofosbuvir | 644401ATB | 625900050 | ±æ¸®¾îµå»çÀ̾ð½ºÄÚ¸®¾Æ(À¯) | 20170086 | 20171106 |
¸¶ºñ·¿Á¤_(1Á¤) | glecaprevir | 669700ATB | 624900290 | Çѱ¹¾Öºêºñ(ÁÖ) | 20200130 | 20201228 |
¸¶ºñ·¿Á¤_(1Á¤) | pibrentasvir | 669700ATB | 624900290 | Çѱ¹¾Öºêºñ(ÁÖ) | 20200130 | 20201228 |
´ÙºñÆ®¶õĸ½¶150¹Ð¸®±×·¥(´Ùºñ°¡Æ®¶õ¿¡ÅؽǷ¹ÀÌÆ®¸Þ½Ç»ê¿°)_(0.17295g/1ĸ½¶) | dabigatran etexilate mesylate (as dabigatran etexilate) | 613702ACH | 654005040 | ¾ÆÁÖ¾àÇ°(ÁÖ) | 20180088 | 20181102 |
´ÙºñÆ®¶õĸ½¶110¹Ð¸®±×·¥(´Ùºñ°¡Æ®¶õ¿¡ÅؽǷ¹ÀÌÆ®¸Þ½Ç»ê¿°)_(0.12683g/1ĸ½¶) | dabigatran etexilate mesylate (as dabigatran etexilate) | 613701ACH | 654005030 | ¾ÆÁÖ¾àÇ°(ÁÖ) | 20180088 | 20181102 |
´ÙºñÄĸ½¶150mg(´Ùºñ°¡Æ®¶õ¿¡ÅؽǷ¹ÀÌÆ®¸Þ½Ç»ê¿°)_(0.17295g/1ĸ½¶) | dabigatran etexilate mesylate (as dabigatran etexilate) | 613702ACH | 052400700 | (ÁÖ)ÀÎÆ®·Î¹ÙÀÌ¿ÀÆĸ¶ | 20180088 | 20181102 |
´ÙºñÄĸ½¶110mg(´Ùºñ°¡Æ®¶õ¿¡ÅؽǷ¹ÀÌÆ®¸Þ½Ç»ê¿°)_(0.12683g/1ĸ½¶) | dabigatran etexilate mesylate (as dabigatran etexilate) | 613701ACH | 052400680 | (ÁÖ)ÀÎÆ®·Î¹ÙÀÌ¿ÀÆĸ¶ | 20180088 | 20181102 |